New research reveals that people who come off popular slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Findings released in a major medical journal shows that while overweight individuals can lose a large proportion of their body weight while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.
"People purchasing such medications should be informed of the potential of fast weight regain when the therapy ends," warns lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to original mass within about 18 months.
Comparing Treatments
The research, which examined dozens of studies involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
The team point out that people who shed pounds through lifestyle changes alone usually experience a slower weight regain—perhaps 100 grams monthly—once they finish.
Understanding the Rapid Regain
Experts propose the way of the jabs accounts for the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which controls feelings of fullness.
"Artificially providing the hormone levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making binge eating much more probable."
A Chronic Condition?
Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
A number of clinicians say that, due to the significant potential of relapse, the therapy should be considered life-long.
This perspective is supported by drug manufacturers, who note that the findings "underscore the persistent nature of excess weight," similar to managing conditions like hypertension.
User Accounts
Individuals who have discontinued the jabs describe a intense return of appetite.
"It felt as if something that goes on and you become ravenous," described one woman.
This difficulty is exacerbated if individuals have not adopted permanent lifestyle or habit changes during treatment.
Widespread Interest
Survey data show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow.
- Use is more common among women than men.
- The 40s and 50s demographic shows the greatest level of interest.
- A large proportion access the drugs through private prescriptions rather than the NHS.
Finally, researchers emphasize that while the jabs are effective agents for shedding pounds, they are not a magic cure and lasting health benefits hinges on integrated lifestyle changes.